Nicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases: Epidemiological Data on Smoking and Preclinical and Clinical Data on Nicotine provides a comprehensive summary of the epidemiological data on smoking and several neurological disorders, including Alzheimer's disease, Parkinson's disease, Multiple Sclerosis, Tourette's syndrome, schizophrenia, anxiety, depression and ADHD, as well as preclinical and clinical data on the effects of nicotine. Despite the obvious and undisputed harmful nature of smoking, evidence suggests that some tobacco and tobacco smoke-derived constituents may offer neuroprotective effects, possibly in combinations, rather than individually. This unprecedented book describes the complex relationships between smoking and neurological disease and the bioactive compounds found in tobacco. It provides a comprehensive review of nicotine and other compounds found in tobacco plant, with scientific evidence of neuroprotective and anti-inflammatory effects that may act in conjunction with nicotine to exert neuroprotective effects observed in smokers. By presenting findings beyond harmful cigarette smoke effects, attention can be drawn to individual compounds of tobacco that may serve as inspiration for further therapy development.

This book is the one I wish I'd come across when I joined the fraternity or soon thereafter. It takes a hard look at some of the non-medical issues you may not have thought about. If it has succeeded, you'll recognize them when they turn up in your life. You'll learn how some other men have dealt with them and get ideas about how you might manage them in your own way. Not least, you'll discover some new ways to think about your situation.

What this book is not about is treating prostate cancer. There are countless volumes on that topic. It's about dealing and living with prostate cancer; about handling unfamiliar situations that are going to arise; about regaining a sense of control; about living productively, well and yes, happily to the outerlimits of possibilities.

This issue of Medical Clinics, guest edited by Drs. Michael P. Pignone and Kirsten Bibbins-Domingo, is devoted to Disease Prevention. Articles in this issue address prevention for various diseases, including: Breast Cancer; Cervical Cancer; Colorectal Cancer; Lung Cancer; Prostate Cancer; and Screening for Depression. Lipids, CV Risk Assessment, Blood Pressure, and Aspirin for Primary Prevention will also be addressed.

Chronic Medical Disease and Cognitive Aging: Toward a Healthy Body and Brain explores the important and often overlooked connection between how chronic medical diseases of the body can affect cognitive function and brain health. As population demographics shift to that of an aging population it has become more important to understand and improve cognitive function in late life. Chronic medical diseases often increase the risk of cognitive impairment, and those with cognitive impairment may be less able to effectively manage their medical conditions, suggesting a reciprocal relationship may exist where medical disease impacts cognition that in turn may exacerbate physical health. Chronic Medical Disease and Cognitive Aging discusses current research on the association between a variety of chronic medical diseases and cognition and, where appropriate, promising interventions or accepted treatment strategies. While a cure for many diseases continues to be elusive, insights garnered from the interplay between diseases of the body and mind may help point the way to novel therapeutic strategies to improve cognitive function in late life.

Inner Hygiene explores the serious health threat of constipation, and discusses the extraordinary variety of preventive and curative measures that have been developed to save people from the toxic effects of intestinal irregularity. The book examines the evolution over the last two centuries of the belief that constipation is a disease brought on by an unnatural lifestyle of urban, industrial society. Particular attention is given to the many constipation therapies that people have used, including laxatives, enemas, mineral waters, bran cereals, yogurts, electrotherapy, calisthenics, rectal dilation devices, and many other remedies. The story is carried up to the present and demonstrates that many of constipation therapies of the nineteenth and twentieth centuries are continuing into the twenty-first.

This next volume in Research in the Sociology of Health Care covers a variety of important social factors and their relationship to health and health care inequities both in the United States and the rest of the world. The authors of this volume explore issues related to infectious diseases and various chronic health problems. One section focuses on Covid 19 and issues of kidney disease, face masks and social values, pandemic experiences in rural parts of the United States, and in urban India. Other topics that are discussed focus on issues outside the United States such as in Nepal, Ecuador, and broader cross-national comparisons. Several papers focus on health care system issues within the United States including micro hospitals in Texas, evidence-based medicine, and trends in health disparities in the Latina population in the United States. Written from a sociological and broader social science approach, the papers provide important information both about broad trends in the US and other countries and some specific considerations of issues from a social perspective as linked to Covid 19.

This book describes how epigenetic context, in a large sense, affects gene expression and the development of an organism, using the asymptotic limit theorems of information theory to construct statistical models useful in data analysis. The approach allows deep understanding of how embedding context affects development. We find that epigenetic information sources act as tunable catalysts, directing ontogeny into characteristic pathways, a perspective having important implications for epigenetic epidemiology. In sum, environmental stressors can induce a broad spectrum of developmental dysfunctions, and the book explores a number of pandemic chronic diseases, using U.S. data at different scales and levels of organization. In particular, we find the legacy of slavery has been grossly compounded by accelerating industrial decline and urban decay. Individual chapters are dedicated to obesity and its sequelae, coronary heart disease, cancer, mental disorders, autoimmune dysfunction, Alzheimer's disease, and other conditions. Developmental disorders are driven by environmental factors channeled by historical trajectory and are unlikely to respond to medical interventions at the population level in the face of persistent individual and community stress. Drugs powerful enough to affect deleterious epigenetic programming will likely have side effects leading to shortened lifespan. Addressing chronic conditions and developmental disorders requires significant large-scale changes in public policy and resource allocation.

This volume includes the information necessary to understand recent critical advances in the mechanisms of intestinal tumorigenesis and to comprehend the complexity of the process. The volume aims to entice new researchers to participate in relevant studies, and to provide a forum for discussion within the scientific community to shape future research in this field. Discoveries in intestinal tumorigenesis lead to further understanding of mechanisms involved in colon cancer. Additionally, advancements in techniques and methods open the doors for new approaches to better define the molecular and organismal mechanisms of intestinal tumorigenesis. Chapters are authored by widely published authorities in the field. Each year, there are close to 150,000 new cases of colorectal cancer, which results in approximately 50,000 deaths per year in the United States; these figures render colorectal cancer a significant health concern. Studies attempting to understand the mechanisms of development and progression of colorectal cancer have been ongoing for decades and each year brings new discoveries yielding a better comprehension of the underlying processes at work.

The conquest of scurvy by James Cook during his three famous circumnavigations of 1768-1780 was a product of Cook's character, of his leadership, and of the wisdom of the naturalists who accompanied Cook; specialists who helped locate antiscorbutic plants during stopovers. In this book, Dr. Cuppage shows the importance of careful observation, and of controlled clinical trials. This is an account of the lasting medical effects of Cook's voyages as he tried to liberate mankind from the scourge of scurvy. Cuppage captures the sense of adventure that explorers and scientists share.

The purpose in writing this book was to fill a void that I noticed in the texts that I was able to read authored by others. I have a unique experience and point of view of musculoskeletal pain honed over 36 years and 45,000 patients. The experience of treating patients directly has been outstanding for me in a professional and personal sense. The advice given in this text is similar to what you would have heard if I had treated you directly. Of course, I have to disclaim any direct results to you if you read this text, because I have not examined you. The ideas are sound, and proven over those many years and great number of patients. The outcome studies verify the validity of the approaches to pain that are written in this text. The approaches we use are scientific, in that the results are predictable, which is the hallmark of science. The examples given as part of the discussion in the text are from my records. This book will empower you to make decisions about your pain.

Mitochondria, the "power plants" of eukaryotic cells, are best known for the generation of adenosine triphosphate (ATP), the universal cellular "energy currency" of the cell, and the synthesis of different essential components. Mitochondrial dysfunction is known to lead to various degenerative disorders, disease, and aging. The Mitochondrion in Aging and Disease works to unravel the processes leading to mitochondrial impairments and of pathways involved in mitochondrial quality control and their impact on health and aging will be addressed.

This new volume of Current Topics in Developmental Biology provides a comprehensive set of reviews on bHLH transcription factors. bHLH factors are vastly recognized for their diverse roles in developmental processes and their dysfunction underlies various human pathologies. Each chapter is authoritatively written by a leading expert in the field and discusses every possible aspect of this huge and diverse field.

This issue is the first of a two-part series on Life-Threatening Infections, edited by Dr. Anand Kumar. Article topics include: Meningitis and other non-viral CNS infections, Encephalitis and viral meningitis, Community Acquired Pneumonia, Hospital Acquired Pneumonia/Ventilator Associated Pneumonia, Clostridial gangrene and bacterial myositis, Acute peritonitis and bowel perforations, Post-operative wound and surgical site infections and Fulminant viral hepatitis.

"Rare Diseases and Orphan Drugs" shows that much of what we now know about common diseases has been achieved by studying rare diseases. It proposes that future advances in the prevention, diagnosis, and treatment of common diseases will come as a consequence of our accelerating progress in the field of rare diseases.

Understanding the complex steps in the development of common diseases, such as cancer, cardiovascular disease, and metabolic diseases, has proven a difficult problem. Rare diseases, however, are often caused by aberrations of a single gene. In rare diseases, we may study how specific genetic defects can trigger a series of events that lead to the expression of a particular disease. Often, the disease process manifested in a certain rare disease is strikingly similar to the disease process observed in a common disease.

This work ties the lessons learned about rare diseases to our understanding of common ones. Chapters covering the number of common diseases are minimized, while rare diseases are introduced as single diseases or as members of diseases classes. After reading this book, readers will appreciate how further research into the rare diseases may lead to new methods for preventing, diagnosing, and treating all diseases, rare or common.
Makes rare diseases relevant to clinicians and researchers by tying lessons learned about the rare diseases to our understanding of the common diseasesStresses basic pathologic mechanisms that account for human disease (e.g., disorders of cell development, replication, maintenance, function and structure), that can be understood without prior training in pathologyDiscusses advanced concepts in molecular biology and genetics in a simple, functional context appropriate for medical trainees and new researchersOffers insights into how further research into rare diseases may lead to new methods for preventing, diagnosing, and treating all diseases.